All articles tagged with #lynch syndrome
A Charlotte woman, 49, who felt exhausted for months underwent a colonoscopy that found a large rectal tumor, diagnosed as Stage 3C cancer; after chemotherapy, radiation and multiple surgeries she is now cancer-free, underscoring the importance of early screening to detect colorectal cancer before it progresses.
Healthy 37-year-old Mohammad Samad experienced abdominal pain, bloating, and constipation that were misattributed to stress, IBS, and Crohn’s disease, delaying a diagnosis of stage-3 colon cancer. After a colonoscopy confirmed the tumor, he underwent chemotherapy and emergency surgery when infections prevented further treatment, the tumor grew to the size of a watermelon, and he required a stoma and nerve damage. He is now cancer-free for two years, with his tumor testing positive for Lynch syndrome, and he has launched a blog to raise awareness about rising cancer rates among young people and the need for earlier screening and awareness.
A phase 1b/2 trial of a preventive cancer vaccine for Lynch syndrome carriers, including Kevin Heyink, showed the vaccine is safe and elicits a lasting immune response. In a 45-participant trial, vaccinated individuals had fewer precancerous lesions and no advanced tumors; Heyink has since had three cancer-free colonoscopies in a row. The vaccine uses a modified adenovirus to train the immune system to recognize Lynch-related proteins, offering hopeful potential to reduce cancer risk, though larger trials are needed before wider use.
A 79-year-old woman with Lynch syndrome is uncertain about continuing colonoscopies due to her age and cardiac risks. Dr. Roach explains that the decision to stop screening depends on individual health and risk factors, noting her lifetime colon cancer risk is about 20%, but her risk decreases with age. Both risks are low, so stopping is reasonable if she prefers, but continuing is also acceptable.
Diane Davis's advanced ovarian cancer was initially thought incurable until molecular testing revealed she had Lynch syndrome, a genetic condition that made her cancer more responsive to immunotherapy, leading to a complete remission and highlighting the importance of genetic testing in cancer treatment.
A woman with advanced ovarian cancer was saved by identifying her rare genetic condition, Lynch syndrome, through molecular testing, which led to effective immunotherapy treatment and a significant remission, highlighting the importance of genetic diagnosis in cancer treatment.
A Newcastle University-led study found that a low dose of 75mg aspirin is as effective as higher doses in reducing cancer risk in patients with Lynch syndrome, potentially leading to updated medical recommendations for this genetic condition.
A long-term study shows that consuming resistant starch, found in green bananas, oats, and pulses, can reduce the risk of various cancers in people with Lynch syndrome by over 60%, especially targeting hard-to-diagnose upper GI cancers, highlighting the potential of dietary changes in cancer prevention.
Lynch syndrome is a little-known genetic disorder that greatly increases the risk of various cancers, including colon, colorectal, uterine, ovarian, stomach, small bowel, kidney, bladder, and brain cancer. Due to its silent nature, 95% of patients with the condition are unaware of it until they develop cancer. Genetic testing through blood or saliva tests can diagnose Lynch syndrome, and those who test positive should undergo regular screenings, especially colonoscopies, to monitor for cancer. A clinical trial for a new cancer vaccine targeting Lynch syndrome patients is underway, with the potential to extend to other types of cancers if successful. It's crucial for individuals to discuss their family history with their primary care doctors and consider genetic testing, as early detection can lead to more frequent screenings and potentially life-saving interventions.
Lynch syndrome is a little-known genetic disorder that significantly increases the risk of various cancers, including colon and colorectal cancer, but is often undiagnosed due to its lack of symptoms. It can be detected through genetic testing and requires close monitoring through regular screenings, especially colonoscopies, for those who test positive. A clinical trial for a new cancer vaccine targeting Lynch syndrome patients is underway, with the potential to extend to other types of cancers if successful. Patients are advised to discuss their family history with their primary care doctors and consider genetic testing for early detection and prevention.
NHS England will offer regular cancer checks to thousands of people with Lynch syndrome, a genetic condition that raises the risk of bowel cancer by up to 80%. The move aims to detect cancers early and save lives. Lynch syndrome, which affects an estimated 175,000 people in England, can be identified through a simple blood test, and those affected can have regular colonoscopies from a young age. The initiative is expected to improve outcomes for people with Lynch syndrome and is part of efforts to improve cancer care in England.
A growing trend of young people in the U.S. developing cancer has been observed, with gastrointestinal cancers, like colorectal cancer, rising fastest. One man, JJ Singleton, ignored his symptoms until he was diagnosed with stage 4 colorectal cancer at age 27. Singleton has Lynch syndrome, a genetic mutation that increases the risk of various cancers in young people. Lack of awareness about Lynch syndrome means many people who could benefit from genetic testing do not get it. Regular screenings and early detection are crucial for those with Lynch syndrome, as it can change the treatment approach. Singleton underwent an immunotherapy clinical trial that successfully shrunk his tumor, allowing him to undergo surgery and improve his quality of life.
A growing trend of more young people in the U.S. developing cancer has been observed, with gastrointestinal cancers, like colorectal cancer, rising fastest. One man, JJ Singleton, ignored his symptoms until he was diagnosed with stage 4 colorectal cancer at the age of 27. He later discovered he had Lynch syndrome, a genetic mutation that increases the risk of various cancers. Lynch syndrome may be a factor in the increasing rates of cancer in young people overall. Genetic testing can help identify Lynch syndrome, and regular screenings can detect cancer at earlier stages. Treatment options, such as immunotherapy, can be tailored based on the presence of Lynch syndrome. Raising awareness about Lynch syndrome and the importance of genetic testing is crucial to help young people prevent and manage cancer.
Genetic testing for hereditary cancer risk is now more affordable and accessible, yet many people who should be offered this testing never hear about it. Experts estimate that about 10% of cancer cases in the US are caused by inherited genetic mutations, but the vast majority of cancer patients never get genetically tested. Lack of knowledge among doctors about the latest testing technology and science, as well as a lack of awareness about the multiple organ risks associated with hereditary cancer syndromes, contribute to the underutilization of genetic testing. Raising awareness and promoting genetic testing could help identify individuals at high risk and potentially catch cancer at an earlier stage.
A 36-year-old woman in the UK was diagnosed with bowel cancer after experiencing symptoms of anemia. Further testing revealed that she had a genetic condition called Lynch syndrome, which increases the risk of certain cancers. Bowel cancer rates among younger people are on the rise. The woman underwent keyhole surgery and chemotherapy, and is now in remission. She emphasizes the importance of recognizing the signs of bowel cancer and raising awareness about the disease, which is often associated with older individuals. Regular screening is crucial for early detection and treatment.